Blood markers study for people with cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected of having an invasive cancer.
- You are 18 years old or older.
- If a tumor biopsy is needed, it must be safe to perform with normal blood clotting.
- You agree to take part and provide written consent.
- You have access to French healthcare coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This study collects blood samples from people with different health conditions (cancer, diabetes, liver disease, etc.) and from healthy volunteers. The goal is to find markers in the blood that could help detect or monitor diseases.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study checks a “biomarker” (a measurable sign in your body, often from blood) in people who are being investigated for possible cancer in a specific body area. It may help researchers understand whether the marker can support or rule out cancer when no cancer has been confirmed yet.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.